Molecular Formula | C18H18F3N3O
|
Molar Mass | 349.35 |
Density | 1.306±0.06 g/cm3(Predicted) |
Boling Point | 395.9±42.0 °C(Predicted) |
Solubility | DMSO: soluble20mg/mL, clear |
Appearance | powder |
Color | white to beige |
pKa | 11.09±0.70(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month. |
Use | SRPIN340 is a selective SRPK inhibitor, acting on SRPK1, Ki is 0.89 μM, and has no significant inhibitory activity on more than 140 other kinases. |
In vitro study | SRPIN340 inhibits SR phosphorylation in Flp-In293 of cells by SRPK and promotes degradation of SRp75 in a dose-dependent manner, followed by inhibition of HIV production. SRPIN340 at 5 mg/ml did not cause abnormalities in chromosome structure and chromosome number in CHO cells. SRPIN340 dose-dependently inhibits the expression of HCV subgenomic replication and HCV-JFH1 clonal replication in vitro. |
In vivo study | SRPIN340 dose-dependently inhibited the formation of CNV in vivo. SRPIN340 significantly reduced the protein levels of VEGF,MCP-1,ICAM-1, thereby inhibiting macrophage infiltration. |